Supply Chain

Survey: 5 attributes providers want when purchasing medical devices

The No. 1 attribute providers ranked as important when purchasing a medical device is consistent outcomes, according to a Vennli survey. By Jessica Kim Cohen - 10/18/17

Every Healthcare Organization Needs Champions of Change to Make Supply Chain Improvements – At All Levels

Sponsored

In an era of increasing uncertainty and rising pressures in healthcare, many health systems are discovering the benefits of getting everybody involved in improving the supply chain.

Study: Cancer drug costs increase 25% in 8 years

The price of injectable brand-name cancer drugs are rising at a pace faster than inflation, according to a study published in the Journal of Clinical Oncology. By Mackenzie Bean - 10/18/17
UnitedHealth not concerned by possibility of Amazon entering drug business

Minnetonka, Minn.-based UnitedHealth Group sees Amazon, who is reportedly exploring entering the pharmaceutical business, as a potential partner rather than a competitor, reports The Star Tribune. By Julie Spitzer - 10/18/17

FDA greenlights OptiScan's bedside glucose monitoring system

The Food and Drug Adminstration on Wednesday granted market clearance to OptiScan Biomedical Corp.'s OptiScanner 5000 Glucose Monitoring System for use in the surgical intensive care unit. By Mackenzie Bean - 10/18/17
The problem with eye drops — and why drug companies won't fix it

Drug companies produce eye drops at a size much larger than the human eye can hold, reports ProPublica. By Mackenzie Bean - 10/18/17
FDA OKs Stryker's knee implant

The Food and Drug Administration on Monday granted market clearance to Stryker's cementless knee implant. By Mackenzie Bean - 10/17/17
Amneal Pharma, Impax will merge into US' 5th largest generics maker

Amneal Pharmaceuticals and Impax Laboratories will combine to form the fifth largest generics business in the country, based on revenue. By Mackenzie Bean - 10/17/17

Drugmakers concerned over the uncertainty of post-Brexit drug regulation

The United Kingdom and European Union have yet to reach a trade deal for medications ahead of Britain's 2019 exit from the EU, according to Bloomberg. By Mackenzie Bean - 10/17/17
This biohacker is creating a recipe book of medicines patients can make at home

Michael Laufer, PhD, a college professor and leader in the growing biohacker movement, wants to teach patients how to make their own medications to subvert the drug industry's high prices, according to STAT. By Mackenzie Bean - 10/17/17
6 drug, devicemakers in the headlines

Here are six drug and medical device companies that made headlines in the past week. By Mackenzie Bean - 10/16/17
Roche taps drug discovery firm to develop new antibiotic classes

Roche formed a strategic collaboration with the drug discovery company Warp Drive Bio to develop new classes of antibiotics. By Mackenzie Bean - 10/16/17

J&J's psoriasis drug OK'd for teens

The Food and Drug Administration on Friday expanded the approval for Johnson & Johnson's psoriasis drug Stelara. By Mackenzie Bean - 10/16/17
FDA approves robotically-assisted surgical device

The FDA approved a new robotically- assisted surgical device, Senhance System, to facilitate minimally invasive surgeries. By Alia Paavola - 10/16/17
Baxter expects temporary shortage of small saline IV bags

Baxter International anticipates a temporary shortage of small saline IV bags in the U.S. due to manufacturing issues in hurricane-damaged Puerto Rico, reports USA Today. By Mackenzie Bean - 10/13/17
4 latest FDA approvals

Here are the four latest drugs and medical devices approved by the Food and Drug Administration in the past week. By Mackenzie Bean - 10/13/17
Medical device venture capital funding falls to $5.8B in 2016

Investment and startup activity in the medical technology sector is in decline, according to a joint report from Deloitte and AdvaMed. By Jessica Kim Cohen - 10/13/17
FDA approves record number of generics in FY 17

The FDA approved a record-breaking number of generic drugs in fiscal year 2017. By Alia Paavola - 10/13/17
Philips to suspend some defibrillator manufacturing in US: 5 things to know

The North American subsidiary of Amsterdam-based Royal Philips reached an agreement on a consent decree with the U.S. Department of Justice, representing the Food and Drug Administration, the company announced Oct. 11. By Jessica Kim Cohen - 10/12/17
7 must-reads for supply chain leaders this week

Here are seven articles Becker's Hospital Review published in the last week, highlighting California's new drug price transparency law and the state of drug manufacturing operations in hurricane-damaged Puerto Rico, among other topics. By Mackenzie Bean - 10/12/17

Page 1 of 50

«
Prev
1
2
3
4
5
6
7
8
9
10
Next
»

Top 40 Articles from the Past 6 Months